Bone Marrow Niches for Hematopoietic Stem Cells and Immune Cells by Sugiyama, Tatsuki & Nagasawa, Takashi
Title Bone Marrow Niches for Hematopoietic Stem Cells andImmune Cells
Author(s)Sugiyama, Tatsuki; Nagasawa, Takashi
CitationInflammation & Allergy - Drug Targets (2012), 11(3): 201-206
Issue Date2012-06
URL http://hdl.handle.net/2433/158206




 Inflammation & Allergy - Drug Targets, 2012, 11, 201-206 201 
 
 2212-4055/12 $58.00+.00 © 2012 Bentham Science Publishers 







Department of Immunobiology and Hematology, Institute for Frontier Medical Sciences, Kyoto University, 53 
Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan 
2
Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Tokyo 
102-0075, Japan 
Abstract: In mammals, hematopoietic stem cells (HSCs), which give rise to all blood cells and their progenies, including 
immune cells are controlled by special microenvironments, termed niches in the bone marrow during homeostasis and 
infection. However, the identity, nature and function of these niches remain unclear. It has been reported that HSCs are in 
contact with osteoblasts lining the bone surface and osteoblasts act as niches for HSCs (termed endosteal niche). 
However, recent studies suggest that only a small number of HSCs reside in the endosteal niche. In contrast, many HSCs 
are shown to be in contact with endothelial cells in the marrow. In addition, recent studies suggest that primitive 
mesenchymal cells, including CXCL12-abundant reticular (CAR) cells and Nestin-expressing cells, which have the ability 
to differentiate into adipocytes as well as osteoblasts act as niches for HSCs. Here we review candidate niches for HSCs in 
the bone marrow controlling hematopoiesis and chronic inflammation. 
Keywords: Bone marrow, chemokine, CXCL12, HSC, niche, SCF, stromal cell. 
INTRODUCTION 
 Hematopoietic stem cells (HSCs) give rise to all lineages of 
blood cells, including immune cells within the bone marrow. 
The bone marrow is surrounded by bone surface and occupies 
the medullary cavities of bones throughout the skeleton and 
contains a dense network of medullary vascular sinuses, and 
blood cells and their precursors are packed in the extravascular 
spaces between the sinuses. It has been assumed that HSCs and 
hematopoietic progenitors reside in the microenvironments in 
the bone marrow, known as niches, which provide HSCs and 
hematopoietic progenitors with regulatory signals essential for 
their maintenance, proliferation and differentiation to produce 
the appropriate numbers of mature blood cells throughout life 
[1-3]. However, niche identity and function are subjects of 
longstanding debate. 
 In 1977, a liquid culture system, in which primitive 
hematopoietic cells proliferated in vitro for several months, 
was reported. This suggests that adherent stromal cells in the 
culture, which might include osteoblasts, endothelial cells 
and macrophages, support hematopoiesis [4, 5]. On the other 
hand, ultrastructural studies suggest that morphologically 
termed adventitial reticular cells that surround vascular 
sinuses are the dominant stromal cells found in bone marrow 
[6]. However, adventitial reticular cells lack distinctive 
characteristics, making it difficult to prove their nature and 
functions as a niche for hematopoiesis in vivo. 
THE ENDOSTEAL NICHE: OSTEOBLASTS, SNO 
CELLS AND OSTEOCLASTS 
 In 1994, primary human osteoblasts were shown to 
maintain the proliferation of primitive hematopoietic  
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progenitors in vitro, raising the possibility that osteoblasts 
are involved in hematopoiesis [7]. Osteoblasts line the bone 
surface and are involved in synthesis, deposition and 
mineralization of extracellular matrix of the bone and play a 
central role in bone development. Subsequently, it was 
reported that parathyroid hormone (PTH) treatment increases 
the numbers of osteoblasts in culture, and increases HSC 
numbers in vivo [8]. In addition, cells which retained BrdU 
after treatment for 10 days followed by a 70-day chase were 
identified as HSCs, and these cells were found in contact 






(SNO) cells, which express a high level of N-cadherin [9]. 
SNO cells line the bone surface but are morphologically 
different from cuboidal (active) osteoblasts. The numbers of 
SNO cells are increased in bone morphogenetic protein 
(BMP) receptor type IA (BMPRIA) conditionally deficient 
mice and this correlates with an increase in the numbers of 
HSCs [9]. In addition, cells expressing Tie2
+
 and N-cadherin 
were identified as HSCs and found in contact with bone-
lining osteoblasts expressing osteocalcin in mice 
myelosuppressed with 5-FU [10]. On the other hand, 
depleting cells of the osteoblastic lineage using a 2.3-kb 
fragment of the rat type I collagen 1 (Col11) gene 
promoter driving thymidine kinase expression (Col2.3TK), 
induced a marked reduction in B cells and erythroid 
progenitors [11, 12]. These results suggested that bone-lining 
osteoblasts, including SNO cells function as a niche for 
HSCs and hematopoietic progenitors (termed endosteal 
niches). 
 However, recent studies complicate the data presented 
above. It was reported that only 4.6% of HSCs retained 









 HSCs were adjacent to the bone 
surface in bone marrow sections [14], and that hematopoiesis 
appeared normal in N-cadherin conditionally-deficient mice 
[15]. Additionally, the receptor for PTH/PTH-related protein 
(PPR), BMPRIA and Col11 are expressed in candidate 
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cellular niches other than osteoblasts, including CXC 
chemokine ligand (CXCL) 12-abundant reticular (CAR) 
cells, described below [16]. Furthermore, the numbers of 
HSCs and blood cells were not reduced in the mice, in which 
osteoblast numbers were reduced [2, 14] and HSC numbers 
were not affected when stem cell factor (SCF), which is 
essential for HSC maintenance, was conditionally deleted 
from osteoblasts [17]. Thus, it remains unclear if osteoblasts 
are a key component of HSC niches. 
 Osteoclasts, which are generated from HSCs and resorb 
the mineralized bone matrix formed by chondrocytes or 
osteoblasts, are located in endosteal niches. The role of 
osteoclasts in hematopoiesis remains a controversial issue. It 
has been reported that osteoclasts degrade endosteal niche 
components and enhance mobilization of hematopoietic 
progenitor cells [18]. In contrast, experiments using mice 
treated with zoledronate, which inhibit osteoclasts suggested 
that mobilization of hematopoietic progenitor cells in 
response to G-CSF is not mediated by osteoclasts [19]. 
Further studies will be needed to clarify how osteoclasts 
regulate hematopoietic stem and progenitor cell behavior. 
THE RETICULAR NICHE FOR HEMATOPOIESIS: 
CXCL12-ABUNDANT RETICULAR (CAR) CELLS 
 The studies focusing on the chemokine CXCL12 
revealed that the specialized reticular cells in marrow 
cavities function as a niche for hematopoiesis. Chemokines 
are a large family of structurally related chemoattractive 
cytokines, which act through seven-transmembrane-spanning 
receptors coupled to heterotrimeric GTP-binding proteins 
(G-protein-coupled receptors) [20]. CXCL12 (also known as 
stromal cell-derived factor [SDF]-1), for which the 
physiological receptor is CXC-chemokine receptor 4 
(CXCR4), was first characterized as a growth stimulating 
factor for a B-cell precursor clone [21-25]. Gene targeting 
studies have revealed that CXCL12-CXCR4 signaling is 
essential for homing and maintenance of HSCs and 
development of immune cells, including B cells, 
plasmacytoid dendritic cells (pDCs), and NK cells in bone 
marrow [22-30]. 
 Immunohistochemical analysis of mice containing the 
green fluorescent protein (GFP) gene knocked into the 
CXCL12 locus (CXCL12-GFP mice) revealed that high 
CXCL12-GFP expression was detected in a small population 
of reticular cells, termed CXCL12-abundant reticular (CAR) 
cells, which are uniformly scattered throughout the bone 
marrow and have the long processes creating a network [29, 







(97%), earliest B cell precursors, plasma cells, pDCs and NK 
cells were in contact with the processes of CAR cells in the 
marrow, suggesting that CAR cells function as a niche for 
HSCs and all immune cells produced in bone marrow 
(reticular niches) [26, 27, 29, 30] (Fig. 1). 
 Histochemical analysis revealed that all bone marrow 
sinusoidal endothelial cells are surrounded by a proportion of 
CAR cells [30] (Fig. 1a); however, CAR cells do not express 
the pan-endothelial marker platelet/endothelial cell-adhesion 
molecule 1 (PECAM-1)/CD31 or the smooth muscle cell 
maker and smooth muscle -actin (SMA), suggesting that 
they are different from endothelial cells and smooth muscle 
cells [29]. Flow cytometric analysis revealed that CAR cells 
do not express CD45, Sca-1 or CD31 and exhibit a mostly 
homogeneous expression of VCAM-1, CD44, platelet-
derived growth factor receptor (PDGFR) and PDGFR, 
suggesting that CAR cells consist of a relatively 































Fig. (1). Mesenchymal progenitors might be key components of 
niches that maintain and regulate HSCs and hematopoietic 
progenitors. (a) A model for the localization of HSCs and their 
association with candidate cellular niches in the bone marrow. Most 
HSCs are in contact with the processes of CAR cells, which are the 
major producer of essential hematopoietic cytokines, including 
CXCL12 and SCF. CAR cells act as niches for HSCs and 
hematopoietic progenitors. Many HSCs are in contact with CAR 
cells surrounding sinusoidal endothelial cells. In contrast, a 
relatively small population of HSCs are in contact with bone-lining 
osteoblasts, including SNO cells, which express a high level of N-
cadherin. It has been reported that the cells which express Nestin in 
the bone marrow are mesenchymal stem cells (MSCs) and function 
as a niche for HSCs and that Sca-1
+
 PDGFR+ subendothelial cells 
are MSCs in the marrow. However, the relationship of the Nestin-
expressing cells with CAR cells and Sca-1
+
 MSCs remains unclear. 
(b) CAR cells are mesenchymal progenitors, which have potential 
to differentiate into adipocytes and osteoblasts, and esseential for 
proliferation of lymphoid and erythroid progenitors and HSCs, and 
maintenance of HSCs in an undifferentiated state. MPP; multipotent 
progenitors. 
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 To clarify the in vivo role of CAR cells, a diphtheria 
toxin receptor (DTR) mouse model selectively ablating CAR 
cells has been generated, in which the numbers of CAR cells 
are severely reduced but other candidate niches, including 
bone-lining osteoblasts or endothelial cells are not affected 2 
days after DT administration [16]. HSCs from the CAR cell-
depleted mice were reduced in number (about 2-fold) and 
cell size, were more quiescent and had increased expression 
of genes involved in myeloid fate decision and 
differentiation. Furthermore, the numbers of cycling B cell 
and erythroid progenitors were reduced in the CAR cell-
depleted mice. In CXCL12-GFP mice, the expression of 
CXCL12 and SCF, which is essential for the proliferation of 
B cell and erythroid progenitors as well as HSCs was higher 
in sorted CAR cells than in other populations from bone 
marrow and bone fractions, and individual CAR cells 
express both CXCL12 and SCF. Consistent with these, the 
short-term ablation of CAR cells in vivo impaired SCF and 
CXCL12 production, indicating that CAR cells are the major 
producer of CXCL12 and SCF in the bone marrow [16]. It 
has been shown that the majority of individual CAR cells 
express both adipogenic and osteogenic genes, including 
PPAR, runx2 and osterix (Osx) and have the potential to 
differentiate into adipocytes and osteoblasts in culture. 
Consistent with this, short-term ablation of CAR cells in vivo 
impaired the adipogenic and osteogenic differentiation 
potential of bone marrow cells [16]. These results suggest 
that CAR cells are adipo-osteogenic progenitors that are 
required for the proliferation of B cell and erythroid 
progenitor and HSCs, and for maintaining HSCs in an 
undifferentiated state. Processes of CAR cells might provide 
hematopoietic stem and progenitor cells with key regulatory 
cytokines [16] (Fig. 1a) although it remains unclear what 
determines the specificity of interaction between certain 
hematopoietic cells and CAR cells. 
 In human bone marrow, the CD146-expressing, subendo-
thelial cells are shown to be skeletal progenitors [31]. The 
abundant CXCL12 expression, multipotency, cell morpho-
logy and location of CD146-expressing subendothelial cells 
suggest that these cells are the human counterparts of CAR 
cells. 
NESTIN-EXPRESSING CELLS 
 Nestin is an intermediate filament protein that was 
originally identified as a marker of neural progenitors [32]. 
Its expression has subsequently been detected in a wide 
range of progenitor cells and endothelial cells [33]. It was 
recently reported that in bone marrow from transgenic mice 
in which GFP is expressed under the control of the neural-
specific regulatory elements of the Nes (Nestin) gene, GFP 
expressing cells, termed Nes-GFP
+
 cells showed an 







 HSCs (60%) were adjacent to Nes-GFP
+
 
cells. In addition, mRNA expression of CXCL12 and SCF 









 non-hematopoietic cells. 
Furthermore, HSC numbers were reduced about 2-fold in the 
marrow but increased in the spleen 16 days after in vivo 
depletion of nestin-Cre-expressing cells using a DTR-
mediated cell knockout technique, suggesting that nestin-




 cells contained cells that formed 
mesenchymal spheres and differentiate into adipocytes and 
osteoblasts, and colony-forming units-fibroblasts (CFU-F). 
Based on these findings, it was concluded that Nes-GFP
+
 
cells are mesenchymal stem cells [34] (Fig. 1). However, the 
frequencies of Nes-GFP
+
 cells with ability to give rise to 
multiple cell types is unclear, and only about 6.9% or 0.7% 
of Nes-GFP
+
 cells possess the ability to form mesenchymal 
spheres or CFU-F, respectively [34], raising the possibility 
that many Nes-GFP
+
 cells are not mesenchymal stem cells. 
In addition, a recent study has shown that nestin-expressing 
cells in the marrow contain some neural cells [35]. Abundant 
expression of CXCL12 and SCF in sorted Nes-GFP
+
 cells 
suggests that nestin-expressing cells contain CAR cells [34]; 
however, significant mRNA expression of nestin was not 
detected in SCF-expressing cells, which would largely 
equate to CAR cells [17]. Consistent with this, HSCs were 
not affected when SCF was conditionally deleted from 







PDGFR+CD34+ cells, which had much 
lower levels of CXCL12 mRNA expression than Sca-1
-
PDGFR+ non-hematopoietic cells (including CAR cells) 
have been reported as a candidate for bone marrow 
mesenchymal stem cell population [36]. Thus, it will be 
important to address the relationship of nestin-expressing 
cells with the Sca-1
+
 mesenchymal stem cell population as 
well as CAR cells and neural cells in the marrow. 
THE ROLE OF CAR AND NESTIN-EXPRESSING 
CELLS IN CHRONIC INFLAMMATION 
 Hematopoietic niches are thought to control 
hematopoiesis not only during homeostasis but also in 
inflammation. Recruitment of inflammatory monocytes as 
well as neutrophils from bone marrow to sites of infection is 
critical for innate immune defense against microbial 
pathogens. It has been shown previously that emigration of 
inflammatory monocytes from bone marrow into the 
circulation during infection with Listeria monocytogenes, an 
intracellular bacterial pathogen requires the chemokine 
receptor CCR2 [37]. The recent study has shown that the 
majority of CCR2
+
 inflammatory monocytes in the bone 
marrow cavities migrate to vascular sinuses and emigrate 
from the marrow into the circulation following low 
concentrations of the Toll-like receptor (TLR) ligands LPS 
[38]. In transgenic mice, in which cells expressing the 
chemokine CCL2, also known as monocyte chemoattractant 
protein-1 (MCP1), a ligand of CCR2, were marked using a 
bacterial artificial chromosome (BAC) mediated transgenesis 
with a linked GFP, the MCP1-GFP expression was 









cells after administration of low concentrations of LPS and 
after infection with Listeria monocytogenes. Sorted MCP1-
expressing cells expressed a high amount of CXCL12 
mRNA following LPS administration. These results strongly 
suggest that the majority of MCP1-expressing cells 
following LPS administration are CAR cells [16, 38, 39]. In 
MCP1 conditional deficient mice, in which the MCP1 gene 
was deleted in MSCs and their progeny, including CAR cells 
and osteoblasts, the numbers of circulating Ly6C
hi
 inflam-
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matory monocytes but not neutrophils was significantly 
reduced after administration of low concentrations of LPS 
[38, 39]. Thus, it is likely that MCP1 up-regulated in MSCs, 
CAR cells and/or osteoblasts is required for inflammatory 
monocyte emigration from the bone marrow into the 
circulation in response to low dose LPS. Together, CAR 
cells responded to circulating microbial molecules and an 
up-regulated expression of another chemokine MCP1, which 
induces migration of inflammatory monocytes in the bone 
marrow cavity to sinusoidal endothelium to enter the 
circulation (Fig. 2). In addition, the results that some MCP1-
expressing CAR cells were located in intersinusoidal spaces 
following the administration of low dose LPS are consistent 
with the fact that not all inflammatory monocytes exit the 
marrow and raise the possibility that MCP1-expressing 
intersinusoidal CAR cells retain some monocytes in the bone 
















Fig. (2). CAR cells respond to circulating microbial molecules and 
up-regulate the expression of another chemokine MCP1, which 
induces migration of inflammatory monocytes in the bone marrow 
cavity to sinusoidal endothelium to enter the circulation. In 
addition, some MCP1-expressing CAR cells located in 
intersinusoidal spaces might retain some monocytes in the bone 
marrow during infection. 
SCF-EXPRESSING CELLS 
 Recently, mice containing the GFP gene knocked into the 
SCF locus (SCF-GFP mice), in which GFP was mainly 
expressed in cells surrounding sinusoidal endothelial cells, 
have been generated [17]. SCF-GFP expressing cells express 
CXCL12 mRNA at particularly high levels, and exhibit a 
homogeneous expression of PDGFR and PDGFR [17]. 
Considering that CAR cells are the major producer of 
CXCL12 and SCF in the marrow, and exhibit a 
homogeneous expression of PDGFR and PDGFR [16], 
SCF-GFP expressing cells would equate to CAR cells. In 
contrast, the results that SCF-GFP expressing cells do not 
express nestin mRNA and that in nestin-Cre, loxP- yellow 
fluorescent protein (YFP) mice EYFP-expressing cells were 
not detected along vascular sinuses suggest that SCF-GFP 
expressing cells are distinct from nestin-expressing cells 
[17]. As for their functional relevance, the numbers of HSCs 
were reduced when SCF was depleted from SCF-GFP 
expressing cells, using leptin receptor (Lepr) –Cre mice, 
based on the fact that mRNA expression of Lepr was highly 
restricted to SCF-expressing cells [17]. 
THE VASCULAR NICHE: ENDOTHELIAL CELLS 
 The arteries enter the bone marrow through the cortical 
bone [40] and continue into typical capillaries that are 
confluent with a complex system of thin-walled sinusoids 
and which ramify throughout the marrow cavity. Some of 
these capillaries have an open lumen, and permits a slow 
blood flow and the passage of blood cells that are generated 









 cells and imaged in tissue sections 








 HSCs are associated with sinusoidal endothelium, 
suggesting that endothelial cells function as a niche for 
HSCs (vascular niches) [41] (Fig. 1). After myeloablation, 
selective activation of Akt1 in the endothelial cells of adult 
mice increases the number of HSCs and accelerates 
hematopoietic recovery [42]. These results do not rule out 
the possibility that endothelial cells indirectly enhance 
proliferation of HSCs by regulating other candidate niches 
closely adjacent to endothelial cells, including CAR cells 
and nestin-expressing cells; however, a recent study revealed 
that the numbers of HSCs were reduced when SCF was 
depleted from endothelial cells, using Tie2–Cre mice, 
indicating that endothelial cells are essential for maintenance 
of a pool of HSCs [17]. Of note, since expression of SCF 
was much lower in bone marrow endothelial cells compared 
with CAR cells (SCF-GFP expressing cells) [16, 17], there is 
the possibility that SCF produced by endothelial cells outside 
bone marrow might be involved in HSC maintenance. It will 
be important to identify additional requisite factors that are 
predominantly expressed in endothelial cells in the bone 
marrow and act directly on HSCs. 
CONCLUDING REMARKS 
 Although HSCs have been reported to be in contact with 
bone-lining osteoblasts and osteoblasts act as niches for 
HSCs, recent studies suggest that only a small subpopulation 
of HSCs reside in the endosteal niche. In contrast, in vivo 
roles for some mesenchymal cells in bone marrow cavities as 
HSC niches have been recently reported [16, 34]. Selective 
short-term ablation of nestin-expressing cells or CAR cells 
has suggested that nestin-expressing cells play an essential 
role in the maintenance of HSC numbers in part by retaining 
HSCs within bone marrow [34] and that CAR cells play a 
critical role in the maintenance of HSCs in a proliferative 
and undifferentiated state [16] although the role of these 
cellular niches in control of HSC quiescence remains 
unclear. Of note, it has been reported that CAR cells and 
nestin-expressing cells have the ability to differentiate into 
osteoblasts and adipocytes, raising the question if these cells 
are involved in bone formation and remodeling. The results 
that cells expressing EYFP from Lepr-Cre, loxP-EYFP mice 
were not detected along bone surface [17] suggesting that 
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lepr-expressing cells, which might largely equate to CAR 
cells, do not give rise to osteoblasts during normal 
development. This is consistent with the fact that adult bone 
lining osteoblasts are derived from osterix-expressing 
precursors in the embryonic perichondrium of developing 
bone during homeostasis [43]. 
 Of the candidate cellular niches for HSCs, SNO and Nes-
GFP
+
, cells seem to be relatively rare non-hematopoietic 
cells that function as niches unique for HSCs. In contrast, 
CAR cells are relatively abundant and might function as a 
niche for both HSCs and more differentiated progenitors, 
including immune cells. In addition, CAR cells have long 
processes and form the reticular network within the bone 
marrow cavity. Considering that osteocytes, the most 
abundant cells in bone, communicate with each other 
through their processes, this raises the possibility that 
processes of CAR cells play a vital role in spatial and 
temporal regulation of their niche function in the bone 
marrow cavities. In this context, it will be important to 
address in future work what determines the specificity of 
niche-hematopoietic cell interaction, and to identify 
molecular mechanisms by which hematopoietic niches 
regulate maintenance, production and exit of various types of 
immune cells during homeostasis, microbial infection and 
inflammatory and myeloproliferative diseases. Furthermore, 
in addition to known PTH and its receptor PPR [8], and LPS 
receptor TLRs [38], molecules which act on cellular niches 
to induce or inhibit expression and/or secretion of requisite 
factors for hematopoietic cell behavior will be a 
pharmacological target for altering niche functions and this 
knowledge is likely to instruct the development of novel 
therapies in the future. 
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